Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial

AIMS: To determine safety of intranasal insulin (INI) in MemAID trial participants with diabetes treated with systemic insulins. MATERIALS AND METHODS: This randomized, double-blinded trial consisted of 24-week INI or placebo treatment once daily and 24-week follow-up. Safety outcomes were: 1) Short...

Descripción completa

Detalles Bibliográficos
Autores principales: Aponte Becerra, L, Galindo Mendez, B, Khan, F, Lioutas, V, Novak, P, Mantzoros, CS, Ngo, LH, Novak, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328174/
https://www.ncbi.nlm.nih.gov/pubmed/35903156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328174/
https://www.ncbi.nlm.nih.gov/pubmed/35903156

Ejemplares similares